OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-06-30-accounts

REGISTERED CHARITY NUMBER 1176132

Report of the Trustees and

Financial Statement for the Year Ended 30 June 2023

for

The Commonwealth Pharmacists Association (CPA)

Commonwealth Pharmacists Association

Contents For The Year Ended 30[th] June 2023

Contents
Report of the Trustees
Independent Examiner’s Report
Statement of Financial Activities
Statement of Financial Position
Notes to the Financial Statements
Detailed Statement of Financial Activities		 Page
3-19
20
21
22
23-31
32

2

Commonwealth Pharmacists Association Report of the Trustees For The Year Ended 30[th] June 2023

The trustees submit their report together with the financial statements of the charity for the year ended 30[th] June 2023.

Chair’s Foreword

It is with considerable pleasure that I sit down to write my first Chair’s Foreword for the Commonwealth Pharmacists Association Annual Report. It is a privilege but also a responsibility to have been invited to take over as Chair of such a successful organisation, lead by our excellent Chief Executive, who has been guided by, in turn, my immediate predecessor interim Chair Raymond Anderson, and before him Roger Odd. My thanks to all three of them for establishing and maintaining an organisation in robust good health.

In the course of the year the Association employed charity consultants Mosaic to provide an independent assessment of our strengths and weaknesses, and of opportunities which might be pursued. The report gave us food for thought about both the short and long terms. In particular, it has given us confidence to start the creation of a staffing structure to support the Chief Executive, in order to free her time to lead the organisation.

This Report reveals a good range of programmes, and a strong financial base. It means the Association, supported by the trustees, must now be ambitious to extend the range and geographical reach of what we do. In saying that, I must acknowledge here the generous financial support we receive from our backers (all listed elsewhere in the Report), and the continuing support of the Royal Pharmaceutical Society in facilitating our work.

Objectives and Activities

The CPA’s charitable objectives are:

Summary of Main Activities

An accredited organisation of the Commonwealth, the CPA is a registered charity, leading and developing the pharmacy profession for the benefit of the people of the Commonwealth. The CPA works collaboratively across the Commonwealth to empower pharmacists to improve health and well-being of the communities they serve. The CPA has a growing collaboration plan with WHO and is in special relations, ensuring the strategic alignment of the CPA’s work to delivering the Sustainable Development Goals (SDGs).

This year, based on its charitable objectives, the CPA has redefined its strategy around three clear strategic goals. These emerged as a result of an external consultancy exercise, and the resulting organisational restructure. Although these goals cut across all programmes of work, our programmes can be categorised according to the primary goal of alignment:

1. Workforce Capability Building , developing the pharmacy workforce and building capacity through education and training. This includes our programmes that have a primary focus on education and training:

3

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

2. Health Systems Strengthening , support pharmacists to strengthen healthcare systems through the safe and effective USE of medicines, prevention of disease and promotion of healthier lifestyles. This includes our programmes that have a primary focus on the health system:

3. Advocacy , embedding pharmacists at all levels of medicines management – enhancing access to and quality of medicines and pharmacy services. This includes work through our official advocacy channels, publications, participation in events and social media campaigns:

For more information visit www.commonwealthpharmacy.org

Public Benefit

Upon appointment, all trustees are required to sign a Code of Conduct that outlines the commitment to CPA’s charitable objectives and working for the benefit of the public. Trustees are formally briefed on and sent the constitution and links to the Charities Commission Guide on the Responsibilities of Trustees on appointment and asked to familiarise themselves with these documents, as part of the trustee induction process.

4

Commonwealth Pharmacists Association Report of the Trustees For The Year Ended 30[th] June 2023

As the charity has grown significantly over the last few years, trustee training has been introduced and took place in October and November 6th December 2023, which will include further emphasis on all Charities Commission’s Guidance, including that relating to public benefit.

Contribution made by volunteers

Volunteer HR and governance/risk advisors have been appointed to support the work of the charity.

Major activities carried out in the reporting period 1st July 2022 – 30th June 2023

1. Workforce Capability Building

1a. Online Continuing Professional Development (CPD) platform

Background:

The Continuing Professional Development (CPD) platform provides pharmacists with key courses to continue their professional development and optimise the care they provide to patients. Both the technological infrastructure and course content have been developed to align with global policy and address global health priorities, as defined by the Commonwealth and WHO. By collaborating with each NPA, the CPA supports both the organisation, helping to build their membership and advocacy efforts, and provides pharmacists with a free resource that supports their professional development. Where applicable, in-country accreditation is obtained through the NPA, enabling pharmacists to use the learning as credits towards their own national CPD requirements.

Aim:

To upskill the pharmacy workforce, building capacity in health systems and improving patient outcomes and safety.

Countries:

Sixteen countries across three continents: Cameroon, Eswatini, Fiji, Gambia, India, Kenya, Lesotho, Malawi, Mauritius, Namibia, Saint Vincent & The Grenadines, Sierra Leone, South Africa, Tanzania, Uganda, Zambia.

Cameroon Eswatini Fiji Gambia India Kenya Lesotho Malawi Mauritius Namibia Saint Vincent & The Grenadines Sierra Leone South Africa Tanzania Uganda Zambia

Timeline:

An ongoing programme to deliver CPD modules relevant for our members every quarter.

Key milestones and deliverables:

Outcomes and Impact:

5

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Next steps and future work:

The CPA continues to source funding to maintain and develop the platform and to ensure that it remains a free resource for all pharmacists across the Commonwealth and beyond. Our platform users want more variety, including case studies and the opportunity to reflect on practice and interactive webinars, which we have incorporated into our work plan for next year.

We have introduced individual membership, which will allow a wider reach of pharmacists across the globe to access our courses beyond the Commonwealth. There will be a focus on promoting individual membership to drive enrolment onto the platform.

1b. Chief Pharmaceutical Officer’s Global Health Fellowships (CPhOGHF)

Background:

Following the announcement of the successful CwPAMS grantees in early February 2019, a cohort of sixteen UK mid-career pharmacists undertook a year-long Chief Pharmaceutical Officer’s Global Health (CPhOGH) Fellowship, in parallel with the CwPAMS, taking on leadership roles to deliver the projects selected by their partnerships. In addition, they completed a short Global Pharmacy Course supported by Brighton & Sussex Medical School as well as an adapted Health Education England (HEE) International Fellowship (IGH) Induction Programme and attended action learning sets provided by the CPA. Each Fellow also worked with a UK-based mentor throughout the Fellowship and undertook a leadership development experience using the NHS Healthcare Leadership model. In 2021, additional funding was secured and a further cohort of thirteen UK mid-career pharmacists who were part of the CwPAMS extension partnerships were enrolled in the fellowship programme, and successfully completed in December 2022.

Ghana Kenya Malawi Nigeria Sierra Leone Tanzania Uganda United Kingdom Zambia

Aims:

CPhOGHF aimed to:

Countries:

Seven countries across 2 continents - Ghana, Malawi, Sierra Leone, Tanzania, Uganda, United Kingdom, Zambia.

Timeline:

The programme was delivered in one year, with completion in December 2022.

6

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Key milestones and deliverables:

Outcomes and Impact:

Next steps and future work:

We look forward to running a third cohort of the CPhOGH Fellowship once funding has been secured.

1c. AMS Leadership Fellowship for Africa Background:

Based on the success of the UK’s Chief Pharmaceutical Officers Global Health Fellows programme, a similar fellowship programme, the Africa Leadership Fellowship-AMS (ALF-A), Ghana has been developed for mid-career pharmacists in Africa that are part of a CwPAMS 2 Kenya partnership. The year-long programme is due to commence in October 2023 during the first Malawi phase of CwPAMS 2. Nigeria Sierra Leone Aims: Tanzania ALF-A aims to: Uganda ● Support AMS capacity building nationally and being key to sustainability. United Kingdom ● Provide mentorship and leadership skills to pharmacists who are part of a CwPAMS Zambia partnership in each LMIC. ● Empower and develop country leaders to continue the mission of tackling AMR in the long term.

7

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Countries:

Eight countries across the African continent - Ghana, Kenya, Malawi, Nigeria, Sierra Leone, Tanzania, Uganda, Zambia.

Timeline:

ALF-A will deliver a 12-month long fellowship programme for 30 pharmacists by December 2024.

Key milestones and deliverables:

Outcomes and Impact:

A total of 68 applications were received for the ALF-A programme from across the eight countries - application review and selection underway.

Published a peer reviewed paper: Ikhile I, Gülpnar G, Iqbal A, Kamere N, Ward B, Halai M, Chan AHY, Muringu E, Munkombwe D, Lawal M, Nambatya W, Esseku Y, Kaminyoghe F, Barlatt S, Muro E, Savieli C, Ashiru-Oredope D, Rutter V.

Scoping of pharmacists' health leadership training needs for effective antimicrobial stewardship in Africa. J Pharm Policy Pract. 2023 Mar 2;16(1):33. doi: 10.1186/s40545-02300543-2. PMID: 36864477; PMCID: PMC9979108.

Next steps and future work:

The next steps include finalising the monitoring and evaluation process, training materials and mentor recruitment and training.

1d. Fundamentals of Critical Care Course

Background: As a result of the COVID-19 pandemic, University College London Hospital (UCLH) began running an online course to upskill pharmacists in critical care knowledge and Bangladesh skills. It was so successful that it is now run virtually each year. Cameroon India Aim: Kenya To collaborate with UCLH and offer 100 free places to Pharmacists Across LMICs of the Malawi Commonwealth to train in the fundamentals of critical care. This was particularly important Mauritius for pandemic preparedness as many pharmacists found themselves working in a critical care Nigeria setting without any training during COVID-19. Pakistan Sierra Leone Key Milestones and Deliverables: St Vincent and CPA negotiated 104 free places, which were offered to pharmacists around the the Grenadines Commonwealth who were involved in critical care to further develop their knowledge and Tanzania skills.

8

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Trinidad and Outcomes and Impact: Tobago Learners completed the course and undertook a survey, feeding back that the course was Uganda valuable in preparing them to work in a critical care setting. Zambia

Next Steps and Future Work:

This will be repeated next year.

2. Health Systems Strengthening

Commonwealth Pharmacists Association
Report of the Trustees
For The Year Ended 30thJune 2023		 Commonwealth Pharmacists Association
Report of the Trustees
For The Year Ended 30thJune 2023		 Commonwealth Pharmacists Association
Report of the Trustees
For The Year Ended 30thJune 2023
Outcomes and Impact:
Learners completed the course and undertook a survey, feeding back that the course was
valuable in preparing them to work in a critical care setting.
Next Steps and Future Work:
This will be repeated next year.
Trinidad and
Tobago
Uganda
Zambia
2. Health Systems Strengthening
2a. PharmAid
Background:
PharmAid, a core membership offering, is an annual scheme that has been running since the
establishment of the CPA in the 1970s.
Aim:
To provide medicines information resources such as pharmaceutical formularies and books,
across the Commonwealth.
Countries:
Six countries across the African continent - Zambia, Ghana, Sierra Leone, Uganda, Malawi
and Tanzania.
Timeline:
The PharmAid scheme is an annual charitable initiative that runs every year. The book
donations run all year round and delivery takes place between July and December.
Key milestones and deliverables:
A cost-benefit exercise was conducted on the PharmAid scheme, revealing its high delivery
cost in its current form. For this reason, the CPA signed a Memorandum of Understanding
with BookAid International to manage the scheme. Amongst the changes introduced in this
partnership is donating and delivering brand new books, the British National Formulary
(BNF) and the British National Formulary for Children (BNFC).
Outcomes and Impact:
4,400 books were requested this year and will be delivered between July - December 2023.
The CPA received requests for book donations of 9,123 books from PharmPress, and 5,566
book request donations from the National Institute for Health and Care Excellence.
Next steps and future work:
The CPA has partnered with BookAid this year who will deliver brand new books to
Commonwealth countries across the African continent where BookAid operates. The CPA is
looking at sourcing other types of Medicines Information books beyond BNF and BNFC.		 Ghana
Malawi
Sierra Leone
Tanzania
Uganda
Zambia

9

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

2b. Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS)

Background:

The Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme aims to tackle antimicrobial resistance (AMR) by supporting low- and middle-income countries (LMICs) to generate, use and share AMR data. The programme is managed by CPA in partnership with the Tropical Health and Education Trust (THET), and is funded by the UK Department for Health and Social Care’s Fleming Fund.

Aim:

CwPAMS aims to leverage the expertise, particularly in pharmacy, of UK health institutions, volunteers and technical experts to strengthen the capacity of the national health workforce and institutions in Commonwealth countries around the following focus areas:

Ghana Kenya Malawi Nigeria Sierra Leone Tanzania Uganda United Kingdom Zambia

Countries:

Nine countries across two continents - Ghana, Kenya, Malawi, Nigeria, Sierra Leone, Tanzania, Uganda, United Kingdom, Zambia.

Timeline:

CwPAMS has been running since 2018 with the first phase successfully ending in June 2022 (CwPAMS 1). A second phase (CwPAMS 2) is currently running from July 2022 to March 2025 (delivered within 2.5 years), supporting new projects and also more mature projects which have been running since the inception of the programme.

Key milestones and deliverables:

10

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Outcomes and Impact:

The impact and lessons learnt from the first phase of the programme were published in peer reviewed journals under various subjects as detailed below: Supply Chain and Antimicrobial Stewardship https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225941

Development and User Feedback on Antimicrobial Stewardship Explainer Videos: - https://www.mdpi.com/2673 9992/15/1/15

Development and Implementation of an Antimicrobial Stewardship Checklist in Sub-Saharan Africa: https://research.bond.edu.au/en/publications/development-and-implementation-ofanantimicrobial-stewardship-ch.

Scoping Review of National Antimicrobial Stewardship Activities in Eight African Countries and Adaptable Recommendations:

11

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Developing and implementing antimicrobial stewardship interventions in four African commonwealth countries through a health partnership model: https://www.publichealthinafrica.org/jphia/article/view/2335

Developing a Board and Online Game to Educate People on Antimicrobial Resistance and Stewardship: The AMS Game:

Next steps and future work:

3c. SPARC - Surveillance and Prescribing Support for Antimicrobial Stewardship Resource Capacity Building

Background:

The Surveillance and Prescribing Support for Antimicrobial Stewardship Resource Capacity Building (SPARC) programme delivers innovative solutions to improve antimicrobial surveillance and prescribing in partner countries with a geographic focus in LMICs in Africa Bangladesh and Asia, to build workforce capability, capacity and resilience in health systems, in the drive Bhutan, for better global antimicrobial stewardship. Eswatini Ghana Aim: India The SPARC programme has two core workstreams: Indonesia 1. Design and build a mobile application, the Prescribing Companion App, to support Kenya prudent antimicrobial prescribing in human and animal health. Laos 2. Support antimicrobial use and surveillance in human health through PPS data Malawi collection on the use of antimicrobials and training in CQI in AMS for Nepal multidisciplinary clinical teams. Nigeria Pakistan Countries: Papua New 22 countries across three continents in Africa, Asia and Oceania - Bangladesh, Bhutan, Guinea Eswatini, Ghana, India, Indonesia, Kenya, Laos, Malawi, Nepal, Nigeria, Pakistan, Papua New Senegal Guinea, Senegal, Sierra Leone, Sri Lanka, Tanzania, Timor Leste, Uganda, Vietnam, Zambia, Sierra Leone Zimbabwe. Sri Lanka Tanzania

12

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Timeline:
SPARC phase 1 was delivered from January 2022 to June 2023. The programme is expected
to extend to December 2023 to support scoping for Phase 2.
Key milestones and deliverables:
● Launch of the Prescribing Companion App and website in November 2022 - an
offline, free to download, and customisable application, available to all 22 countries.
● GlobalPPS training and data collection delivered in 5 countries.
● CQI training delivered to clinical specialists in 5 countries.
Outcomes and Impact:
Workstream 1
● Thirteen App champions (super users) from thirteen countries trained in app
customisation and maintenance. Countries include:
○
Uganda, Zimbabwe, Ghana, Bangladesh, Nepal, Nigeria, Timor-Leste, Kenya,
Tanzania, Zambia, Malawi, Bhutan, Sierra Leone.
● Ten national guidelines published on the Prescribing Companion App.
● International AMS/IPC core module made available to all 22 countries through the
Prescribing Companion App and website.
Outcomes and Impact:
Workstream 2 and 3
● GPPS training delivered across 25 sites in 5 countries: Malawi, Nepal, Nigeria, Timor
Leste, Zimbabwe - 50 data collectors.
● CQI for clinicians serving over 10,700 inpatients.
● 12 million patient population served across PPS sites.
Next steps and future work:
● SPARC is expected to be extended to December 2023 to support:
● Further development and deployment of the Prescribing Companion App.
● Use of collected antimicrobial use data for action.
● Scoping for SPARC 2.
● Separate web pages are under development for SPARC, the Prescribing Companion
App, CQI and PPS and App Champion Tools page.		 Timor Leste
Uganda
Vietnam
Zambia
Zimbabwe
3d. Commonwealth Voluntary Information and Price Sharing Database
Background:
The Commonwealth Voluntary Information and Price Sharing Database (VIPSD) is an
initiative that was developed following the 2018 Commonwealth Health Ministers
deliberation to establish an information sharing mechanism between member states. The
Commonwealth Secretariat initiated the process for the development of the VIPSD, an
electronic database that aims to increase equitable access to essential medicines, health
commodities and procurement data assisting informed decision making when sourcing
essential medicines. Endorsed in May 2021 by Commonwealth Health Ministers, the
database’s uptake and deployment has been low.
Aim:
The first phase of the project (June - November 2023) will build the foundation for the scale
up activities focusing on:
● Scoping the procurement landscape in select Member States to understand the
scope andgaps of available databases. Findings will inform further development of		 All
Commonwealth
countries

13

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

an updated and relevant database.

Countries:

20 select countries across five regions of the Commonwealth. The E. Caribbean, SADAC, ASEAN, Malta / Europe and the Pacific.

Timeline:

VIPSD will be delivered between June to November 2023.

Key milestones and deliverables:

Next steps and future work:

Systematic deployment of the VIPSD over the 56 Member states within the Commonwealth (Dec 2023 and beyond).

3. Advocacy

3a. Digital Campaigns

The CPA has an annual calendar of health campaigns that they support and promote that are relevant to the Commonwealth and aligned to our strategic goals.

The purpose of these campaigns is to raise awareness of health issues affecting the Commonwealth and the role of pharmacists in tackling these, encouraging and empowering pharmacists around the Commonwealth to better serve their communities.

All Commonwealth countries

Two of the largest campaigns run each year are around World Antimicrobial Awareness week and Commonwealth Pharmacists Day.

World Antimicrobial Awareness Week

During World Antimicrobial Awareness Week (November 2022), the CPA in partnership with the International Pharmaceutical Federation (FIP), culminated a series of six ‘AMS in Action’ webinars (where CwPAMS impact was showcased) with further promotion of the CwPAMS resources and physical AMS board games were offered as prizes to winning individuals who shared their innovative solutions of tackling AMR. Three patient representatives were invited to share their personal experiences and the meetings were widely disseminated beforehand on social media and live tweeted during the events.

Commonwealth Pharmacists Day

Background:

The Commonwealth Pharmacists Day, celebrated annually on the 16th of June, is a dedicated occasion to recognize and appreciate the crucial role pharmacists perform in the healthcare systems spanning the 56 Commonwealth nations.

14

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Theme for 2023:

The chosen theme for this year was “Your Pharmacist, Your Partner in Health.”

Main Campaign:

The core of the campaign for 2023 was centred around self-representation, enabling pharmacists from across the Commonwealth to participate actively. This involved:

Promotion and Outreach:

Article Publication: An article detailing the theme, significance of the day, and participation methods was published prior to the event. It garnered significant traction with over 4,000 views and approximately 1,700 complete reads. Victoria Rutter, the CEO, wrote an article dedicated to the occasion, which was subsequently shared across all official social media channels.

Newsletter: On the day, a newsletter was circulated to approximately 11,000 pharmacists within the Commonwealth community. It achieved a 33% open rate, translating to over 4,000 recipients actively engaging with its content.

Flyer Distribution: Over 1,500 personalised flyers were created and shared by pharmacists throughout the Commonwealth. Generic flyers promoting Commonwealth Pharmacists Day were disseminated extensively across various social media platforms.

3b. Advocacy around Substandard and Falsified Medicines at CHMM

Background:

Substandard and Falsified Medicines (SFMs) are a growing threat to the public health of nations, with an estimated 1:10 medicines in low/middle-income countries (LMICs) to be substandard or a fake. SFMs result in ineffective treatment and harm to patients, eroding people’s trust in health systems and governmental efforts to fight communicable and noncommunicable diseases. Weak and fragmented regulation further exacerbates the problem in many countries. We must minimise the impact of SFMs to improve patient safety and public health.

All Commonwealth countries

Aim:

To write and present a paper to CHMM with a call to action for health ministers to develop a co-ordinated and urgent response.

15

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Milestones and Deliverables: Successful submission of paper.

Outcomes and Impact:

The recommendation was also presented as a recommendation from Civil Society to the Health Ministers and was taken up into the CHMM ministerial statement.

Next Steps:

This work will be followed up through the CPA's SF medicines work streams that are part of our portfolio of programmes and further advocacy built into future Commonwealth government meetings.

3c. Research & Dissemination

The CPA has an active research programme, with over 35 publications since 2018, All highlighting the impact of our programmes and issues around access to, and use of, Commonwealth countries medicines as well as the full breath and expertise of pharmacists in these fields.

A full list of publications can be found on the CPA Website: https://commonwealthpharmacy.org/publications

During 2023, we have also developed and delivered a total of 10 conference abstracts, 8 poster presentations and 4 conference talks, including: ● 3 abstracts to the International Pharmaceutical Federation Congress (Brisbane, Australia) - these resulted in 1 oral and 2 poster presentations. ● 3 abstracts to the Royal Pharmaceutical Society Conference (London, UK) - these resulted in 3 poster presentations. ● 3 abstracts to the Federation of Asian Pharmacists Association Conference (Taipei, Taiwan) - these resulted in 3 oral and 3 poster presentations. ● 1 abstract to the International Conference on Public Health in Africa (Lusaka, Zambia). We continue to work to ensure continuous communication and dissemination of our work to achieve high impact.

Financial Review

The Charity has remained stable after rapid growth in the previous year, reflected in a turnover for the year of £790K (2022: £852K).

The Charity’s core unrestricted fund shows a surplus of £19K increasing the core funds from £88K to £107K. This is in line with the reserves policy to build the resilience of the organisation. Designated funds show a surplus of £21K increasing the reserves from £4K to £25K.

Restricted funds have increased with a surplus of £2K to £186K (2022: £184K) which reflect the unspent funds for project activity that extends over the next 2 financial years.

The Charity begins the new financial year in a good financial position. The total funds carried forward are £319K (2022: £277K).

16

Commonwealth Pharmacists Association Report of the Trustees For The Year Ended 30[th] June 2023

Reserves Policy

Reserves are held to help the charity operate efficiently. The unrestricted reserves are that part of the charity’s funds that are freely available to spend on the charity’s purposes. Whilst ensuring that the charity holds at least three months of unrestricted funds to cover running costs, the reserves policy also looks at building up reserves for unforeseen expenditure which will strengthen the resilience of the charity. Unforeseen expenditure can include a shortfall in income, temporary cash flow issues, uncontrolled costs, trustee liability, sudden closure. A decision to carry £83K in unrestricted reserves would be deemed prudent and will be reviewed quarterly considering a growing team of employed staff. These reserves would be held to cover:

Income risk £18,000 Working capital reserve £19,500 Cessation reserve £45,500

The current reserves of £133K are therefore adequate.

Principal sources of funds:

Principal Risks

The CPA has a strategic risk register in addition to those relating to individual projects. The risks to the charity have been identified as:

  1. Breach of Data Protection regulations/law

  2. Insufficient unrestricted funding

  3. Incident arising as a consequence of non-compliance with legislation or policy.

  4. Inability to deliver the CPA annual work programme as the organisation evolves.

  5. Trustees may fail to understand and deliver on their role.

  6. Inability to meet contractual commitments due to poor cash flow management.

The response and mitigations relating to these risks are detailed in the strategic risk register and are reviewed monthly by the senior management team and every quarter in liaison with the Board of Trustees. A further indepth review of the risk register took place on 10[th] October 2023.

Structure, Governance and Management

The charity is governed by the constitution accepted in December 2017, and adopted in July 2018 when the CPA officially began functioning as a Charitable Incorporated Organisation (CIO). This replaced the original constitution that related to the establishment of the unincorporated charity that was adopted in Dec 2015.

17

Commonwealth Pharmacists Association Report of the Trustees For The Year Ended 30[th] June 2023

The charity is a CIO consisting of 25 member organisations (2022: 36) and over 10,023 individual members (2022: 9000) to date. Traditionally the CPA has been an association of member organisations. Individual reach is expected to continue to grow in line with the relationships and collaborative working opportunities developed.

Trustees

In accordance with the constitution, there are:

Organisational Structure

The CPA is governed by the board of Trustees.

The Chief Executive Officer reports to the board of trustees and manages the day to day running of the organisation, working with the CPA team of staff, consultants, and volunteers.

The CPA’s council and regional assembly (previously referred to as ‘executive’) consist of representatives from the national pharmacy associations (NPAs) of the Commonwealth, from which the President and Vice president are elected. These bodies serve as an advisory board to the CPA, helping to set and deliver the strategy.

The CPA is in a unique position in terms of the organisation’s established and potential relationships, particularly in terms of:

Reference and Administration Details

Charity name: The Commonwealth Pharmacists Association Charity’s Commission registered number: 1176132 Charity’s principal address: 66-68 East Smithfield, London, E1W 1AW

18

Commonwealth Pharmacists Association

Report of the Trustees For The Year Ended 30[th] June 2023

Trustees during the year were:
Tony Downes Chair Appointed 6th Dec 2022
Raymond Anderson Acting Chair to 6th Dec 2022
Mary Anne Ciappara President
Biyi Oloko Treasurer
Claire Anderson
Zaheer Babar
Manjula Halai Appointed 6th Dec 2022
Oksana Pyzik
David Reissner Appointed 7th Feb 2023
Claire Thompson Appointed 6th Dec 2022
Rao Vadlamudi
Volunteer Advisors:
Matthew Hayday Governance & Risk Advisor
Independent Examiner:
Vicky Newham CPAA Solutions Accountancy & Bookkeeping Ltd
Other key personnel:
Victoria Rutter Chief Executive Officer
Josie Malloy Business & Finance Manager Appointed 2nd Jan 2023
Tatiana Hardy Senior Administrator Resigned 31st Oct 2022

Public Benefit

When planning the activities for the year, the trustees have complied with their duty in Section 4 of the Charities Act 2011 to have due regard to guidance published by the Charity Commission, including public benefit guidance.

The trustees have approved the report above and have authorised us to sign it on their behalf.

_________ Biyi Oloko – Treasurer

Date of approval: 20[th] November 2023

19

Commonwealth Pharmacists Association Independent Examiners Report For The Year Ended 30[th] June 2023

I report on the accounts for the year ended 30[th] June 2023 set out on pages 22 to 32.

Respective responsibilities and basis of report

The charity's trustees are responsible for the preparation of the accounts in accordance with the Charities Act 2011("the Act").

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's financial statements as carried out under section 145 of the Charities Act 2011 ('the 2011 Act').

In carrying out my examination, I have followed the Directions given by the Charity Commission under section.

145(5)(b) of the 2011 Act.

Independent examiner's statement:

As the charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of CPAA.

I have completed my examination. I confirm that no material matters have come to my attention

in connection with the examination which gives me cause to believe that in, any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Vicky Newham CPAA Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL

Date: 04 December 2023

20

Commonwealth Pharmacists Association

Statement of Financial Activities

For The Year Ended 30[th] June 2023

Notes
INCOME AND ENDOWMENTS
FROM
Donations
2
Total Donations and legacies
Charitable activities
Grant income
3
Individual subscriptions
Membership fees
Member association fees
Total Charitable activities
Total Income
EXPENDITURE ON
Charitable activities
4
Total Expenditure
Net Income
Transfers
Net Movement
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD
CONTINUING OPERATIONS
All income and expenditure have arisen		 Unrestricted
funds
Restricted
funds
£
£
916
0
916
0
60,000
709,254
300
0
19,437
0
0
0
79,737
709,254
80,653
709,254
40,239
707,327
40,239
707,327
40,414
1,927
(133)
133
40,281
2,060
92,735
184,268
133,016
186,328
from continuing activities		 2023
Total funds
£
916
916
769,254
300
19,437
0
788,991
789,907
747,566
747,566
42,341
0
42,341
277,003
319,344		 2022
Total funds
Restated
£
16,148
16,148
810,491
225
17,309
8,000
836,025
852,173
670,866
670,866
181,307
0
181,307
95,696
277,003

21

Commonwealth Pharmacists Association

Statement of Financial Activities

For The Year Ended 30[th] June 2023

Notes
FIXED ASSETS
Tangible assets
9
CURRENT ASSETS
Debtors
10
Cash at bank in hand
11
CREDITORS
Amounts falling due within one
year
12
NET ASSETS
FUNDS
13
Unrestricted funds
Restricted funds
TOTAL FUNDS		 2023
£
513
221,352
213,057
434,410
(115,579)
319,344
133,016
186,328
319,344		 2022
£
711
47,692
352,880
400,572
(124,894)
277,003
92,735
184,268
277,003

The financial statements were approved by The Board of Trustees on 20[th] November 2023 and were signed on its behalf by:

________ Biyi Oloko – Treasurer

The notes form part of these financial statements.

22

Commonwealth Pharmacists Association Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1st January 2015)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.

Going concern

There are no material uncertainties about the charity’s ability to continue so it is regarded as a going concern.

Financial reporting standard 102 – reduced disclosure exemptions

The charity has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received, and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings, they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets

Depreciation is provided at the following annual rates of write off each asset over its estimated Office Equipment -25% on cost.

Fund’s structure

Funds held by the charity are either:

Unrestricted funds - these are funds which can be used in accordance with the Charity's objects at the trustees' discretion.

Designated funds – included within unrestricted funds, these are funds which can be used in accordance with the Charity’s objects at the trustees’ discretion and have been assigned for specific areas of activity.

Restricted funds - these funds can only be used for restricted purposes within the objects of the Charity. Restrictions arise when specified by the donor or where funds are raised for restricted purposes.

Comparative figures

The comparative figures have been restated to better reflect the appropriate analysis of certain items of income and expenditure in accordance with the SORP, resulting in no changes to income, expenditure, net movement in funds or fund balances.

Further explanations of the nature and purpose of each fund are included in the notes to the accounts.

24

Commonwealth Pharmacists Association Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

2. DONATIONS AND LEGACIES

Unrestricted:
Other donations
3. GRANT INCOME
Unrestricted Designated:
Novartis Pharma AG
International Pharmaceutical Association (FIP)
Restricted:
Fleming Fund (CwPAMS 2.0)
Fleming (SPARC)
Pfizer
Commonwealth Secretariat: Price Sharing Database
Royal Pharmaceutical Society grant
Menarini: AMD CPD
Fleming Fund (CwPAMS 1.5)
Health Education England
Sir Halley Stewart Trust
4. CHARITABLE ACTIVITIES COSTS
Unrestricted
funds
£
Direct costs
32,083
Administration costs
8,156
40,239		 Restricted
funds
£
674,263
33,064
707,327		 2023
£
916
2023
£
40,000
20,000
312,373
223,992
125,000
23,600
14,289
10,000
0
0
0
769,254
2023
Total funds
£
706,346
41,220
747,566		 2022
£
Restated
16,148
2022
£
Restated
110,000
0
0
510,075
0
0
25,000
0
120,416
30,000
15,000
810,491
2022 Total
funds
£
Restated
609,430
61,436
670,866

25

Commonwealth Pharmacists Association

Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

5. SUPPORT COSTS

Advance health and education
Activity
Basis of allocation
Governance costs
Apportioned on an estimated use
basis as follows:
Advance health and education		 2023
£
33,064
33,064
%
100
100		 2022
£
20,574
20,574
%
100
100

6. TRUSTEES’ REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year (2022: £Nil).

There were trustee travel expenses paid in the year of £23 for 1 trustee (2022: £Nil for 0 trustees).

7. STAFF COSTS

Wages and salaries
Pension
Employer National Insurance contributions
Overtime
The average monthly number of employees during the year was as follows:
Staff		 2023
2022
£
£
77,417
4,347
3,383
19,361
69,014
2,715
2,631
0
104,508
74,360
2023
2022
No.
No.
Restated
1.7
1.3

No employees received emoluments, including pension contributions, in excess of £60,000 (2022: None)

The Charity has a pension scheme set up with NEST for the benefit of staff. New staff have the option of joining the NEST scheme or continuing to pay into their existing personal pensions.

The amount of pension contributions charged to the charity in the year was £4,347 (2022: £2,715). The amount of pension contributions outstanding at the end of the year was £249 (2022: £796).

26

Commonwealth Pharmacists Association

Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

INCOME AND ENDOWMENTS FROM
Donations and legacies
Charitable activities
Grant income
Individual subscriptions
Membership fees
Member association fees
Total
EXPENDITURE ON
Charitable activities
Total
NET INCOME
Transfers between funds
Net movement in funds
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Unrestricted
funds
£
Restated
16,148
110,000
225
17,309
8,000
151,682
127,259
127,259
24,423
0
24,423
68,312
92,735		 Restricted
funds
£
Restated
0
700,491
0
0
0
700,491
543,607
543,607
156,884
0
156,884
27,384
184,268		 2022
Total funds
£
Restated
16,148
810,491
225
17,309
8,000
852,173
670,866
670,866
181,307
0
181,307
95,696
277,003

26

Commonwealth Pharmacists Association Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

9. TANGIBLE FIXED ASSETS

COST
At 1st July 2022
Disposal
At 30th June 2023
DEPRECIATION
At 1st July 2022
Charge for year
Disposal
At 30th June 2023
NET BOOK VALUE
At 30th June 2023
At 30th June 2022		 Office
Equipment
£
1,722)
(824)
898)
1,011)
198)
(824)
385)
513
711

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Grant income
Subscriptions
Accrued income
Prepayments		 Unrestricted
funds
£
0
492
0
1,222
1,714		 Restricted
funds
£
205,465
0
13,565
608
219,638		 2023
Total funds
£
205,465
492
13,565
1,830
221,352		 2022
Total funds
£
Restated
40,705
6,987
0
614
48,306

27

Commonwealth Pharmacists Association

Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

11. CASH AT BANK IN HAND

Unity Trust Bank
PayPal Account
Soldo Account		 Unrestricted
funds
£
132,500
2,843
2,098
137,441		 Restricted
funds
£
75,617
0
0
75,617		 2023
Total funds
£
208,117
2,843
2,098
213,058		 2022
Total funds
£
351,402
0
1,478
352,880

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Trade creditors
Deferred income
Accruals
Bad debt provision
Pension Contributions
HMRC Creditor		 Unrestricted
funds
£
1,096
246
5,061
0
249
0
6,652		 Restricted
funds
£
68,784
35,711
2,497
0
0
1,935
108,297		 2023
Total funds
£
69,880
25,000
7,558
0
249
1,935
115,579		 2022
Total funds
£
92,363
25,000
1,620
4,800
796
315
124,894

Additional information regarding the deferred income is shown at note 15

28

Commonwealth Pharmacists Association Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

13. MOVEMENTS IN FUNDS
Unrestricted funds
General fund
Designated funds
Novartis Pharma AG
FIP
Restricted funds
Fleming Fund (SPARC)
Health Education England
Fleming Fund (CwPAMS 1.5)
Fleming Fund (CwPAMS 2.0)
Pfizer
Commonwealth Secretariat
Royal Pharmaceutical Society
Menarini AMS CPD		 At 1 July
2022
£
Restated
88,478
4,257
0
167,869
11,453
4,946
0
0
0
0
0
277,003		 Incoming
resources
£
20,653
40,000
20,000
223,992
0
0
312,373
125,000
23,600
14,289
10,000
789,907		 Outgoing
resources
£
(17,356)
(18,930)
(3,953)
(391,861)
(11,529)
(556)
(273,079)
(8,754)
(0)
(14,289)
(7,259)
(747,566)		 Transfers
At 30
June 2023
£
£
15,914)
107,689
0
25,327
(16,047)
0
0
0
76)
0
(4,390)
0
4,447)
43,741
0
116,246
0
23,600
0
0
0
2,741
0
319,344

Designated funds:

Commenced December 2021 and aiming to complete activities and costs by December 2023. The Novartis funds have been treated as designated as there is a detailed plan of activities.

Restricted funds:

29

Commonwealth Pharmacists Association Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

- Fleming Fund/CwPAMS 1.5

CwPAMS: A health partnership scheme funded by the UK Government Department of Health and Social Care’s Fleming Fund. Managed by THET. The CwPAMS networking platform was developed by BSAC for use by partners in the CwPAMS programme in partnership with the Commonwealth Pharmacists’ Association (CPA). The forum will allow the sharing of skills and knowledge between multidisciplinary NHS teams, including or led by pharmacists with hospitals in Ghana, Tanzania, Uganda and Zambia, and expand capacity for antimicrobial stewardship. This initial programme ran until June 2022. The small amount of underspend was carried over to CwAMS 2.0.

- Fleming Fund/CwPAMS 2.0

The current programme commenced in July 2022 as a continuation of CwPAMS 1.5 and will run to June 2024. A restricted fund with a very detailed and strictly controlled budget in collaboration with THET. The figures introduced into the budget are lifted directly from the formal agreement. Funds are received partly in advance and partly in arrears.

To increase the number of Pharmacists in low/middle income countries (LMICs) accessing and completing locally relevant Continuing Professional Development (CPD) courses via an online CPD platform. The target population includes Latin America, Africa, the Middle East, Southeast Asia and beyond.

The core purpose of the CPD platform is to support in upskilling the pharmacy workforce, building capacity in health systems and ultimately improving patient care and safety. The objectives are:

The total grant of £125,000 has been received and partially spent up to June 2023. The remaining funds of £116K are due to be spent in the forthcoming year.

Objectives:

30

Commonwealth Pharmacists Association

Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

Grant of £24K received in advance from the Commonwealth Secretariat. The programme will run for 6 months from September to Feb 2024.

Objectives:

14. RELATED PARTY DISCLOSURES

The Royal Pharmaceutical Society (RPS) granted the charity £25,000 in the year January 2023 (2022: £25,000) to help pay for the core salary costs for the charity.

The RPS received free annual subscription to the Commonwealth Pharmacists Association in the year ended 30th June 2023 which had a value of £7,354 (2022: £7,354).

15. COST OF INDEPENDENT EXAMINATION AND OTHER PROFESSIONAL SERVICES

The amount payable to the independent examiner was as follows:

2023 2022
£ £
Cost of external scrutiny 1,780 1,620

31

Commonwealth Pharmacists Association

Notes to the Financial Statement - continued For The Year Ended 30[th] June 2023

INCOME AND ENDOWMENTS
Donations and legacies:
Donations
Total Donations and Legacies
Charitable activities:
Grant income
Membership fees
Individual subscriptions
Associate membership fees
Total Charitable Activities
Total Incoming Resources
EXPENDITURE
Charitable Activities:
Direct costs and contractors’ fees
Gross salaries, NI and pension
Technical support
Accountancy and payroll
Insurance
Consultancy fees
Telephone, stationery, office supplies
Travel and subsistence
Subscriptions
Bank charges and exchange differences
Software
Staff welfare and training
Recruitment
Depreciation of IT equipment
Admin support from programmes
Total Charitable Activities
Total Outgoing Resources
NET INCOME
Transfers
NET MOVEMENT		 Unrestricted
funds
£
916
916
60,000
19,437
300
0
79,737
80,653
32,082
16,930
10,462
2,366
2,241
1,687
1,662
1,320
1,131
1,071
850
656
647
198
(33,064)
40,239
40,239
40,414)
(133)
40,281		 Restricted
funds
£
0
0
709,254
0
0
0
709,254
709,254
674,263
0
0
0
0
0
0
0
0
0
0
0
0
0
33,064
707,327
707,327
1,927
133
2,060		 2023
Total
funds
£
916
916
769,254
19,437
300
0
788,991
789,907
706,346
16,930
10,462
2,366
2,241
1,687
1,662
1,320
1,131
1,071
850
656
647
198
0
747,566
747,566
42,341
0
42,341		 2022
Total
funds
£
Restated
16,088
16,088
810,551
17,309
225
8,000
836,085
852,173
609,430
44,712
5,271
2,261
2,087
1,500
673
508
2,041
350
1,357
400
89
187
0
670,866
670,866
181,307
0
181,307

32